Related references
Note: Only part of the references are listed.Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility
C. Has et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Effect of ropivacaine on peripheral neuropathy in streptozocin diabetes-induced rats through TRPV1-CGRP pathway
Nanwen Zhang et al.
BIOSCIENCE REPORTS (2019)
Impact of Painful Wound Care in Epidermolysis Bullosa During Childhood: An Interview Study with Adult Patients and Parents
Petra J. Mauritz et al.
ACTA DERMATO-VENEREOLOGICA (2019)
Advancement in management of epidermolysis bullosa
Heather I. Cohn et al.
CURRENT OPINION IN PEDIATRICS (2016)
Pain care for patients with epidermolysis bullosa: best care practice guidelines
Kenneth R. Goldschneider et al.
BMC MEDICINE (2014)
Population pharmacokinetic analysis of ropivacaine and its metabolite 2′,6′-pipecoloxylidide from pooled data in neonates, infants, and children
L. Aarons et al.
BRITISH JOURNAL OF ANAESTHESIA (2011)
Share Paper
